Medical Research News

Nursing

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Winzenberg T et al. - Gout afflicts about 2% of men over age 30 and women over age 50 and its prevalence appears to be increasing. Options for treating acute gout include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and intra-articular and systemic corticosteroids. Choosing among them can be challenging, however, because the evidence that one or another of these options yields real benefit is of varying strength. Using NSAIDs can be problematic with increasing age, as comorbidities like gastrointestinal (GI) bleeding, renal failure, heart failure, and cardiovascular risk increase and anticoagulant therapy is more likely to be in use. That’s where the kind of systematic reviews Cochrane Musculoskeletal Group (CMSG) performs can be of real help.

Related Articles

Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09    Relevance Score: 69%

Progress in Measurement Instruments for Acute and Chronic Gout Studies
Journal of Rheumatology, 10/23/09    Relevance Score: 68%

The modern management of gout
Rheumatology, 10/08/09    Relevance Score: 66%

Acute chylous ascites mimicking acute appendicitis in a patient with pancreatitis
World Journal of Gastroenterology, 10/20/09    Relevance Score: 47%

Acute silent cerebral infarction in children with sickle cell anemia
Pediatric Blood & Cancer, 10/09/09    Relevance Score: 46%

Today in Clinical Pharmacology...keeping you current

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09

Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09